In terms of the Group Sustainable Development Policy, the Clinical Performance and Sustainability Committee annually reviews the Group’s material sustainability issues to ensure management initiatives are directed at those sustainable development issues that are most signifi cant to the business, and which directly aff ect the Group’s ability to create value for its key stakeholders.